HERKULES/ PLZRWZW00012 /
2024-04-25 11:28:47 AM | Chg. +0.02 | Volume | Bid9:10:00 PM | Ask9:10:00 PM | High | Low |
---|---|---|---|---|---|---|
0.83PLN | +1.97% | 3,302 Turnover: 2,612.56 |
-Bid Size: - | -Ask Size: - | 0.83 | 0.79 |
GlobeNewswire
03-27
Erasca Reports Fourth Quarter 2023 and Full Year 2023 Business Updates and Financial Results
GlobeNewswire
2023-11-28
Erasca Achieves Key Milestones for Naporafenib and ERAS-801 Programs and Extends Cash Runway
GlobeNewswire
2022-03-10
Erasca Announces Clinical Trial Collaboration and Supply Agreement with Eli Lilly and Company to Eva...
GlobeNewswire
2021-09-22
Erasca Announces First Patient Dosed in HERKULES-3, a Phase 1b/2 Gastrointestinal Cancer Master Prot...
GlobeNewswire
2021-09-09
Erasca Announces First Patient Dosed in HERKULES-2 Phase 1b/2 Lung Cancer Master Protocol Evaluating...
GlobeNewswire
2021-09-08
Erasca Announces Clinical Trial Collaboration and Supply Agreement with Pfizer to Evaluate ERAS-007 ...
GlobeNewswire
2018-04-18
Global Wheelchair Lift Market 2018-2023: Key vendors for the $2.6 Bn Market are BraunAbility, Bruno ...
GlobeNewswire
2018-03-29
Nokia wins its largest-ever GSM-Railway contract with Polish PKP Polskie Linie Kolejowe to modernize...
GlobeNewswire
2018-03-29
Nokia wins its largest-ever GSM-Railway contract with Polish PKP Polskie Linie Kolejowe to modernize...
GlobeNewswire
2012-12-05
Pronova BioPharma ASA : Offer Document from BASF Approved by the Oslo Stock Exchange
GlobeNewswire
2012-11-21
Pronova BioPharma ASA: Pronova BioPharma Receives Voluntary Cash Offer from BASF
GlobeNewswire
2009-04-30
Preliminary announcement of financial statements for the period 1
February 2008 - 31 January 2009